top of page

Georgios S. Stamatakos, father of in silico medicine, is Research Professor of Analysis and Simulation of Biological Systems and their Interaction with Electromagnetic Radiation at the Institute of Communication and Computer Systems (ICCS), School of Electrical and Computer Engineering (SECE), National Technical University of Athens (NTUA). He has  also been a Visiting Professor at the Medical School, University of Saarland (Medizinische Fakultät, Universität des Saarlandes), Germany,  (1 Jul. - 15 Sept 2019). From 2016 to 2019 he was a Visiting Professor at SECE, NTUA. G. Stamatakos is the Founder and the Director of the In Silico Oncology and In Silico Medicine Group of ICCS-SECE-NTUA (

He holds a Diploma (MSc) degree in electrical engineering from NTUA, an MSc degree in bioengineering from the University of Strathclyde, Glasgow, UK, and a Ph.D. degree in physics (biophysics) from NTUA. He has also been a postdoctoral fellow in medical technology at ICCS-NTUA as a National Grant Foundation (IKY) grant recipient.

Ηe has published more than 160 articles in international peer reviewed journals, conference proceedings and scientific books (including book chapters).

His research interests include, inter alia, in silico oncology, in silico medicine, multiscale cancer modeling, biomedical applications of Artificial Intelligence (AI) with special emphasis on oncology, computational medicine, systems medicine, precision medicine, the Virtual Physiological Human (VPH) initiative, systems biology, bioinformatics, artificial intelligence, biomedical engineering, bioengineering, bioelectromagnetics, biooptics, computational electromagnetics, software engineering, statistics and applied mathematics.

Ηe has taught several courses at both undergraduate and postgraduate levels at SECE and the School of Applied Mathematical and Physical Sciences of NTUA as well as at the Hellenic Army's Postgraduate School of Telecommunications (STIAD). Τhese include, inter alia, electromagnetic fields and microwaves, optoelectronics laboratory courses, laser technology and applications laboratory courses and physics laboratory courses.

He formulated and proposed the postgraduate course (705-SECE-NTUA) entitled: "Multiscale Cancer Modeling and In Silico Medicine", which he has been teaching in SECE, NTUA since 2014. The latter has turned out to be the first postgraduate course dedicated to the emergent domain of in silico medicine on a global scale ( The course description is available at .

G. Stamatakos has served as advisor for many diploma and doctoral theses in SECE.

He proposed the concept and the system of the "Oncosimulator" (video available at He pioneered the development of the Oncosimulator of the EC and Japan co-funded ACGT Integrated Project, a "world first" ( He also led the development of the Oncosimulators of several other competitive EC funded and international projects, mostly centered around the initiative of the Virtual Physiological Human (VPH) initiative (ContraCancrum, TUMOR, p-medicine, DR THERAPAT, MyHealthAvatar etc.). A major clinical collaborator in his research endeavours has been Norbert Graf, Professsor of Clinical Oncology and Hematology, University of Saarland, Germany.

G. Stamatakos was the scientific and the overall coordinator as well as the leader of the fundamental science part of the large scale EU-US integrating research project CHIC on in silico oncology ( The latter was funded by the European Commission with a grant of 10,582,000 €. Seventeen leading academic, research, clinical and industrial partner organizations across Europe and US participated in CHIC. The CHIC project underwent its final review on 23 and 24 May 2017 and was assessed as "Excellent" by the Board of five External Reviewers appointed by the European Commission. A press release article on the "great achievements" of the CHIC project is available on the official website of the European Commission at A list of the major achievements of CHIC is available at A related news article published on the SECE website is available on

He is currently leading the predictive computer models action of the EU funded H2020 project BOUNCE entitled: “Predicting Effective Adaptation to Breast Cancer to Help Women to BOUNCE Back.” (Project ID: 777167, )

He proposed the term and the concept of "In Silico Oncology" denoting a new clinical trial driven scientific and technological discipline, primarily based on multiscale mechanistic biomodelling and in silico experimentation (i.e. experimentation on the computer). In Silico Oncology has also proved a precursor of the generic in silico medicine (

Since 1st July 2019 (and till 15th September 2019) he has been working at the Medical School, University of Saarland, Germany, as an invited Visiting Professor, focusing on the clinical validation of the pioneering multiscale Oncosimulator of paediatric nephroblastoma which was designed and developed at ICCS-SECE-NTUA under his leadership and the clinical support of Prof. N. Graf, Medical School, University of Saarland (

He (co-)initiated and (co-)organized a number of international research workshops, including the IARWISOCI series on in silico oncology and cancer investigation ( - open access to the Proceedings) and the First Transatlantic (EU-US) Workshop on Multiscale Cancer Modeling (ICT 2008, Brussels 2008, A video of the opening talk of the latter delivered by G. Stamatakos is available at the ecancer oncology portal: He was an organizer and invited speaker at the Virtual Physiological Human (VPH2018) Conference dedicated to in silico medicine. This conference took place in Zaragoza, Spain on 5-6 Sept. 2018 (

Georgios Stamatakos was co-editor, contributor and reviewer of the transatlantic multi-author textbook entitled "Multiscale Cancer Modeling" published by CRC Press in 2010/2011 ( and The US co-editor of the book was Thomas Deisboeck, MD, Associate Professor, Massachusetts General Hospital and Harvard Medical School. He was also co-editor of the Proceedings of the six international IARWISOCI conferences on in silicooncology and cancer investigation.

He serves as a referee for numerous scientific peer reviewed journals including Nature Reviews Clinical Oncology and Nature Scientific Reports. G. Stamatakos is a Member of the Editorial Board of Cancer Informatics and a member of IEEE, the Virtual Physiological Human (VPH) Institute and the Technical Chamber of Greece.

He is an expert of the European Research Council (ERC) established by the European Commission. 

In 2019 G. Stamatakos was elected a member of the three member Board of Trustees of the Virtual Physiological Human Institute (VPHi) (

The address of G. Stamatakos' webpage on the international researchers' database ORCID is

bottom of page